loading
Precedente Chiudi:
$0.4654
Aprire:
$0.473
Volume 24 ore:
228.54K
Relative Volume:
0.61
Capitalizzazione di mercato:
$45.28M
Reddito:
$5.12M
Utile/perdita netta:
$-67.00M
Rapporto P/E:
-0.315
EPS:
-1.47
Flusso di cassa netto:
$-38.94M
1 W Prestazione:
-5.65%
1M Prestazione:
-16.58%
6M Prestazione:
-70.72%
1 anno Prestazione:
-93.14%
Intervallo 1D:
Value
$0.4461
$0.4996
Intervallo di 1 settimana:
Value
$0.4369
$0.51
Portata 52W:
Value
$0.3816
$11.41

Verrica Pharmaceuticals Inc Stock (VRCA) Company Profile

Name
Nome
Verrica Pharmaceuticals Inc
Name
Telefono
484-453-3300
Name
Indirizzo
10 NORTH HIGH STREET, WEST CHESTER, PA
Name
Dipendente
71
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-11
Name
Ultimi documenti SEC
Name
VRCA's Discussions on Twitter

Confronta VRCA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
VRCA
Verrica Pharmaceuticals Inc
0.4639 45.28M 5.12M -67.00M -38.94M -1.47
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
489.42 128.67B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
585.18 60.99B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
600.02 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
236.34 29.89B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
253.34 26.16B 3.81B -644.79M -669.77M -6.24

Verrica Pharmaceuticals Inc Stock (VRCA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-11-06 Downgrade H.C. Wainwright Buy → Neutral
2024-11-05 Downgrade RBC Capital Mkts Outperform → Sector Perform
2023-07-25 Aggiornamento Needham Hold → Buy
2023-03-22 Iniziato Jefferies Buy
2023-02-13 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2022-05-25 Downgrade RBC Capital Mkts Outperform → Sector Perform
2021-05-14 Iniziato RBC Capital Mkts Outperform
2020-12-24 Reiterato H.C. Wainwright Buy
2020-07-15 Downgrade BofA Securities Buy → Neutral
2020-06-30 Reiterato H.C. Wainwright Buy
2020-06-24 Iniziato Northland Capital Outperform
2020-03-24 Iniziato Needham Buy
2019-02-21 Iniziato H.C. Wainwright Buy
Mostra tutto

Verrica Pharmaceuticals Inc Borsa (VRCA) Ultime notizie

pulisher
Apr 18, 2025

GLP-1 Receptor Agonist Market Is Booming Worldwide 2025-2032: Verrica Pharmaceuticals, AbbVie Inc. - newstrail.com

Apr 18, 2025
pulisher
Apr 18, 2025

Leadership Changes at Madrigal Pharmaceuticals Mark New Phase of Growth - MyChesCo

Apr 18, 2025
pulisher
Apr 13, 2025

Verrica Pharmaceuticals Appoints Dr. Noah Rosenberg as Chief Medical Officer - MSN

Apr 13, 2025
pulisher
Apr 13, 2025

Verrica Pharmaceuticals (NASDAQ:VRCA) Earns "Neutral" Rating from HC Wainwright - MarketBeat

Apr 13, 2025
pulisher
Apr 11, 2025

New Drug Application Submitted in Japan for Verrica Pharmaceuticals’ TO-208 - MSN

Apr 11, 2025
pulisher
Apr 11, 2025

Needham & Company LLC Reiterates “Hold” Rating for Verrica Pharmaceuticals (NASDAQ:VRCA) - Defense World

Apr 11, 2025
pulisher
Apr 11, 2025

HC Wainwright Analysts Decrease Earnings Estimates for VRCA - Defense World

Apr 11, 2025
pulisher
Apr 10, 2025

What is HC Wainwright’s Forecast for VRCA FY2028 Earnings? - Defense World

Apr 10, 2025
pulisher
Apr 09, 2025

Verrica Pharmaceuticals (NASDAQ:VRCA) Receives “Neutral” Rating from HC Wainwright - Defense World

Apr 09, 2025
pulisher
Apr 09, 2025

Verrica Pharmaceuticals Reports Strong First-Quarter Growth for YCANTH - MSN

Apr 09, 2025
pulisher
Apr 09, 2025

H.C. Wainwright maintains Neutral on Verrica stock after Q1 update By Investing.com - Investing.com Canada

Apr 09, 2025
pulisher
Apr 08, 2025

Verrica Pharmaceuticals at Needham Conference: Strategic Restructuring and Growth By Investing.com - Investing.com Canada

Apr 08, 2025
pulisher
Apr 07, 2025

In face of U.S. stock market selloff, shares of West Chester firm are on the rise - The Business Journals

Apr 07, 2025
pulisher
Apr 07, 2025

Verrica Pharmaceuticals Reports Strong Demand-Led Growth In Ycanth® In Q1 2025 - marketscreener.com

Apr 07, 2025
pulisher
Apr 07, 2025

Verrica Pharmaceuticals Reports Strong Demand-Led Growth in YCANTH® Dispensed Applicator Units in First Quarter 2025 - The Manila Times

Apr 07, 2025
pulisher
Apr 07, 2025

Verrica Pharmaceuticals Reports Strong Demand-Led Growth in - GlobeNewswire

Apr 07, 2025
pulisher
Apr 07, 2025

Record-Breaking Quarter: YCANTH Crosses 10K Units Milestone with 17% Growth - Stock Titan

Apr 07, 2025
pulisher
Apr 05, 2025

Verrica Pharmaceuticals Adds Dr. Gavin Corcoran to Board of Directors - MSN

Apr 05, 2025
pulisher
Apr 03, 2025

Here's Why Verrica Pharmaceuticals (VRCA) Is a Great 'Buy the Bottom' Stock Now - MSN

Apr 03, 2025
pulisher
Apr 03, 2025

Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors - The Manila Times

Apr 03, 2025
pulisher
Apr 03, 2025

Verrica Pharmaceuticals appoints new board member - Investing.com Australia

Apr 03, 2025
pulisher
Apr 02, 2025

Verrica Pharmaceuticals appoints new board member By Investing.com - Investing.com Canada

Apr 02, 2025
pulisher
Apr 02, 2025

Palvella Therapeutics Announces Late-Breaking Presentation at Global Pediatric Dermatology Congress - MyChesCo

Apr 02, 2025
pulisher
Apr 02, 2025

Verrica Pharmaceuticals expands board with new director By Investing.com - Investing.com Canada

Apr 02, 2025
pulisher
Apr 02, 2025

Verrica Pharmaceuticals Appoints Dr. Corcoran as Director - TipRanks

Apr 02, 2025
pulisher
Apr 02, 2025

Verrica Pharmaceuticals expands board with new director - Investing.com

Apr 02, 2025
pulisher
Apr 02, 2025

Strategic Move: Verrica Adds Formation Bio CDO to Board Amid YCANTH Success - Stock Titan

Apr 02, 2025
pulisher
Apr 02, 2025

Verrica Pharmaceuticals to Present at Needham Healthcare Conference - MSN

Apr 02, 2025
pulisher
Apr 02, 2025

Palvella Therapeutics Reports 2024 Financial Results and Advances Rare Disease Pipeline - MyChesCo

Apr 02, 2025
pulisher
Apr 01, 2025

Harmony, Lungpacer, Verrica and Arbutus make C-suite hires - The Business Journals

Apr 01, 2025
pulisher
Mar 31, 2025

Verrica Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

Exclusive: Verrica Pharmaceuticals CEO Fireside Chat at Major Healthcare Conference - Stock Titan

Mar 31, 2025
pulisher
Mar 26, 2025

Verrica Pharmaceuticals appoints new CMO to advance skin treatments By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer - GlobeNewswire

Mar 26, 2025
pulisher
Mar 26, 2025

Verrica Pharmaceuticals appoints Rosenberg as CMO - MSN

Mar 26, 2025
pulisher
Mar 26, 2025

Verrica Pharmaceuticals appoints new CMO to advance skin treatments - Investing.com

Mar 26, 2025
pulisher
Mar 26, 2025

Dermatology Drug Pioneer Joins Verrica to Accelerate YCANTH Growth - Stock Titan

Mar 26, 2025
pulisher
Mar 25, 2025

VRCA stock plunges to 52-week low, touches $0.5 - Investing.com

Mar 25, 2025
pulisher
Mar 19, 2025

Verrica Pharmaceuticals Inc (VRCA)’s stock price range in the last year - US Post News

Mar 19, 2025
pulisher
Mar 18, 2025

Verrica Pharmaceuticals Reports Positive Q4 2024 Results - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

Verrica Pharmaceuticals’ chief legal officer sells shares for $2,804 By Investing.com - Investing.com South Africa

Mar 18, 2025

Verrica Pharmaceuticals Inc Azioni (VRCA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$19.80
price down icon 1.75%
$70.30
price up icon 2.22%
$32.51
price up icon 0.87%
$26.24
price up icon 1.84%
$102.53
price down icon 0.01%
biotechnology ONC
$248.35
price up icon 8.46%
Capitalizzazione:     |  Volume (24 ore):